September 27, 2018

Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 26, 2023

    Eli Lilly Gets $177M Teva Migraine Drug Patent Verdict Tossed

    A Massachusetts federal judge overturned a $176.5 million migraine drug patent infringement verdict that Teva Pharmaceuticals won against Eli Lilly & Co., finding Tuesday that the three patents related to Teva's product Ajovy are invalid.

11 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login